0001193125-26-259705.txt : 20260605 0001193125-26-259705.hdr.sgml : 20260605 20260605163007 ACCESSION NUMBER: 0001193125-26-259705 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260604 FILED AS OF DATE: 20260605 DATE AS OF CHANGE: 20260605 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: POST LEONARD E CENTRAL INDEX KEY: 0001235862 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41925 FILM NUMBER: 261069561 MAIL ADDRESS: STREET 1: C/O CG ONCOLOGY, INC. STREET 2: 400 SPECTRUM DRIVE SUITE 2040 CITY: IRVINE STATE: CA ZIP: 92618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CG Oncology, Inc. CENTRAL INDEX KEY: 0001991792 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences EIN: 371611499 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3000 PEGASUS PARK DRIVE STREET 2: SUITE 1640 CITY: DALLAS STATE: TX ZIP: 75247 BUSINESS PHONE: (949) 409-3700 MAIL ADDRESS: STREET 1: 3000 PEGASUS PARK DRIVE STREET 2: SUITE 1640 CITY: DALLAS STATE: TX ZIP: 75247 4 1 ownership.xml 4